India’s biggest medicine-making company, Sun Pharmaceutical Industries, is planning to acquire a US company called Organon.
Following the hard-won success of early anti-amyloid drugs, a new generation of Alzheimer’s modalities—from tau-targeting ...
Parnassus Core Select ETF (PRCS) targets 25 high-quality large-cap stocks for long-term growth. Read the full analysis for ...
Neuren Pharmaceuticals has projected DAYBUE global net sales to hit US$700 million by 2028. The post Neuren Pharmaceuticals ...
China's pharmaceutical industry surges on ageing demand and global expansion, with revenue forecast to top US$2.1 trillion by ...
SAN FRANCISCO, CA / ACCESS Newswire / January 14, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company’s founder, president and CEO, will present virtually on Thursday ...
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is one of the best debt-free penny stocks to buy right now. On December 17, ...
In 2025, businesses spent an aggregate of $633 million to build, expand or improve facilities, according to Lake County ...
Pharmaceutical companies have raised prices on hundreds of drugs so far this month despite federal efforts to rein in drug ...
TheFly reported on January 9 that Citi upgraded CAH from Neutral to Buy, raising the price target from $190 to $244.
TOKYO, JAPAN, January 14, 2026 / EINPresswire.com / — LOTTE Holdings, Co., Ltd. (Tokyo, Japan; CEO: Genichi Tamatsuka, ...